JP2016508036A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508036A5
JP2016508036A5 JP2015550089A JP2015550089A JP2016508036A5 JP 2016508036 A5 JP2016508036 A5 JP 2016508036A5 JP 2015550089 A JP2015550089 A JP 2015550089A JP 2015550089 A JP2015550089 A JP 2015550089A JP 2016508036 A5 JP2016508036 A5 JP 2016508036A5
Authority
JP
Japan
Prior art keywords
seq
fragment
variant
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015550089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508036A (ja
JP6461810B2 (ja
Filing date
Publication date
Priority claimed from EP12425208.1A external-priority patent/EP2749569A1/en
Application filed filed Critical
Publication of JP2016508036A publication Critical patent/JP2016508036A/ja
Publication of JP2016508036A5 publication Critical patent/JP2016508036A5/ja
Application granted granted Critical
Publication of JP6461810B2 publication Critical patent/JP6461810B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015550089A 2012-12-28 2013-12-27 Bpifb4タンパク質の変異体 Active JP6461810B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12425208.1A EP2749569A1 (en) 2012-12-28 2012-12-28 Variant of BPIFB4 protein
EP12425208.1 2012-12-28
PCT/EP2013/078076 WO2014102343A1 (en) 2012-12-28 2013-12-27 Variant of bpifb4 protein

Publications (3)

Publication Number Publication Date
JP2016508036A JP2016508036A (ja) 2016-03-17
JP2016508036A5 true JP2016508036A5 (cg-RX-API-DMAC7.html) 2017-02-09
JP6461810B2 JP6461810B2 (ja) 2019-01-30

Family

ID=47715813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015550089A Active JP6461810B2 (ja) 2012-12-28 2013-12-27 Bpifb4タンパク質の変異体

Country Status (8)

Country Link
US (4) US20150344536A1 (cg-RX-API-DMAC7.html)
EP (4) EP2749569A1 (cg-RX-API-DMAC7.html)
JP (1) JP6461810B2 (cg-RX-API-DMAC7.html)
CN (1) CN104955836B (cg-RX-API-DMAC7.html)
AU (1) AU2013369292B2 (cg-RX-API-DMAC7.html)
CA (1) CA2896166A1 (cg-RX-API-DMAC7.html)
ES (2) ES2731126T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014102343A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2749569A1 (en) * 2012-12-28 2014-07-02 Annibale Alessandro Puca Variant of BPIFB4 protein
CN104558144B (zh) * 2014-12-30 2017-08-08 深圳市第二人民医院 鼠Bpifb5突变体、蛋白及其应用
CN111094327A (zh) * 2017-08-16 2020-05-01 Lgv1有限公司 Bpifb4蛋白的用于神经元疾病和损伤的vtft同种型
EP4434534A1 (en) 2023-03-22 2024-09-25 ADvantage Therapeutics, Inc. Klotho mrna

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) * 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
JP2004500829A (ja) * 2000-04-18 2004-01-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 新規な脂質結合タンパク質4
EP1379654A2 (en) 2001-02-08 2004-01-14 Incyte Genomics, Inc. Intracellular signaling molecules
EP1463805B1 (en) 2001-12-17 2014-10-22 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
WO2006022619A2 (en) * 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
EP2027296A4 (en) * 2006-05-31 2010-06-02 Philadelphia Children Hospital COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING T-CELL-IMMUNE ATTACHMENTS TO VIRAL VECTORS USED IN GENDER THERAPY
CN101622348A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为治疗性干预靶标的miR-20调节的基因和途径
EP2019143A1 (en) 2007-07-23 2009-01-28 Genethon CNS gene delivery using peripheral administration of AAV vectors
WO2010071832A1 (en) 2008-12-19 2010-06-24 Nationwide Children's Hospital Delivery of polynucleotides across the blood brain barrier using recombinant aav9
JP2011231022A (ja) * 2010-04-23 2011-11-17 Ajinomoto Co Inc イミダゾロン誘導体
CN103502458B (zh) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
EP2749569A1 (en) * 2012-12-28 2014-07-02 Annibale Alessandro Puca Variant of BPIFB4 protein

Similar Documents

Publication Publication Date Title
US20230210887A1 (en) Nucleic acid molecules for reduction of papd5 or papd7 mrna for treating hepatitis b infection
JP2026041749A5 (cg-RX-API-DMAC7.html)
EP2281040B1 (en) Lyophilized dna formulations for enhanced expression of plasmid dna
JP2014512808A5 (cg-RX-API-DMAC7.html)
JP2018536405A (ja) 心臓状態および他の病態の処置のための複数の生物学的に活性なポリペプチドを単一のベクターから発現させるための組成物および方法
JP2016518325A5 (cg-RX-API-DMAC7.html)
US20240271139A1 (en) Engineered Guide RNAs and Polynucleotides
JP2006502702A5 (cg-RX-API-DMAC7.html)
JP2018509154A5 (cg-RX-API-DMAC7.html)
CN116785309A (zh) 环状rna在制备用于预防和/或治疗缺血性卒中药物中的应用
US11466276B2 (en) Stem-loop compositions and methods for inhibiting factor D
JP6461810B2 (ja) Bpifb4タンパク質の変異体
WO2017016430A1 (zh) 一种肿瘤抑制肽
CN104288781B (zh) miR‑329在制备预防和/或治疗缺血性眼部疾病的药物中的应用
CN104288764B (zh) Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用
JP2025510946A5 (cg-RX-API-DMAC7.html)
CN113846098B (zh) 一种小rna及其在心血管疾病治疗中的用途
US12540330B2 (en) Stem-loop compositions and methods for inhibiting vascular endothelial growth factor
WO2022187671A1 (en) Compositions and methods for the treatment of hemophilia
JPWO2009013794A1 (ja) インスリン分泌誘導剤及び膵臓β細胞増加促進剤
JP2023509067A (ja) コドン最適化TIF1γポリヌクレオチドを含む組換えベクターおよびその用途
WO2003091271A1 (en) Alternatively spliced nucleic acid molecules
CN105985983B (zh) 一种治疗2型糖尿病的aav载体及其制备方法和应用
CN103601808A (zh) 新型钠肽、制备方法及其在制备基因工程药物中的应用
EP4093427B1 (en) Pro-anp for use in the treatment of cardiac remodelling